Clinical Trial Update: Vancomycin in Primary Sclerosing Cholangitis in Italy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating vancomycin for primary sclerosing cholangitis in Italy. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: University of Milano Bicocca | Conditions: Primary Sclerosing Cholangitis, Liver and Intrahepatic Bile Duct Disorder | Phase 2 | Status: RECRUITING